Since the Company’s acquisition of its Mio-Guard business in March 2022, Mio-Guard has generated strong revenues and has grown its sales by more than 25% in calendar year 2022 compared to calendar year 2021.

Source: https://forextv.com/top-news/salona-global-closes-acquisition-of-arrowhead-medical-provides-update-on-biodex-integration-posts-first-quarter-results-with-positive-adjusted-ebitda-23-annual-revenue-growth-and-27-growth-in-annua/

Since the Company’s acquisition of its Mio-Guard business in March 2022, Mio-Guard has generated strong revenues and has grown its sales by more than 25% in calendar year 2022 compared to calendar year 2021.

Source: https://forextv.com/top-news/salona-global-closes-acquisition-of-arrowhead-medical-provides-update-on-biodex-integration-posts-first-quarter-results-with-positive-adjusted-ebitda-23-annual-revenue-growth-and-27-growth-in-annua/